Ta Hsung Tung

Array ( [id] => 11762274 [patent_doc_number] => 09370565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-21 [patent_title] => 'Dendritic cell co-stimulatory molecules' [patent_app_type] => utility [patent_app_number] => 14/068966 [patent_app_country] => US [patent_app_date] => 2013-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 30129 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14068966 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9449452 [patent_doc_number] => 20140120622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'T CELL MODIFYING COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/051244 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25628 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14051244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9293916 [patent_doc_number] => 20140037551 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'ANTIBODIES TO HUMAN B7X FOR TREATMENT OF METASTATIC CANCER' [patent_app_type] => utility [patent_app_number] => 14/050512 [patent_app_country] => US [patent_app_date] => 2013-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9366 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14050512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10628736 [patent_doc_number] => 09346882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Fully human antibodies to BTLA' [patent_app_type] => utility [patent_app_number] => 14/031319 [patent_app_country] => US [patent_app_date] => 2013-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 37580 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14031319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9581984 [patent_doc_number] => 08771987 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Mammalian cell lines for increasing longevity and protein yield from a cell culture' [patent_app_type] => utility [patent_app_number] => 14/030526 [patent_app_country] => US [patent_app_date] => 2013-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 29 [patent_no_of_words] => 18553 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14030526 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9868847 [patent_doc_number] => 08956615 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-02-17 [patent_title] => 'Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same' [patent_app_type] => utility [patent_app_number] => 14/025981 [patent_app_country] => US [patent_app_date] => 2013-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16684 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14025981 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9408054 [patent_doc_number] => 20140099306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'CTLA4 FUSION PROTEINS FOR THE TREATMENT OF DIABETES' [patent_app_type] => utility [patent_app_number] => 14/021629 [patent_app_country] => US [patent_app_date] => 2013-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10830 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14021629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11772490 [patent_doc_number] => 09381244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'VISTA modulators for diagnosis and treatment of cancer' [patent_app_type] => utility [patent_app_number] => 14/021353 [patent_app_country] => US [patent_app_date] => 2013-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 72 [patent_no_of_words] => 97113 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14021353 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10354973 [patent_doc_number] => 20150239978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'ANTIBODIES DIRECTED AGAINST ICOS FOR TREATING GRAFT-VERSUS-HOST DISEASE' [patent_app_type] => utility [patent_app_number] => 14/424092 [patent_app_country] => US [patent_app_date] => 2013-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7506 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9191029 [patent_doc_number] => 20130330344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'ANTIBODY MOLECULES HAVING SPECIFICITY FOR HUMAN OX40' [patent_app_type] => utility [patent_app_number] => 13/973189 [patent_app_country] => US [patent_app_date] => 2013-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21369 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13973189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9191023 [patent_doc_number] => 20130330338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'CTLA4 PROTEINS AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 13/968139 [patent_app_country] => US [patent_app_date] => 2013-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 30608 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 54 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13968139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9197670 [patent_doc_number] => 20130336985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'MEDICAMENT AND A METHOD FOR REGULATION OF THE VASCULAR TONE' [patent_app_type] => utility [patent_app_number] => 13/966339 [patent_app_country] => US [patent_app_date] => 2013-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2594 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13966339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9330114 [patent_doc_number] => 20140056896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'ANTI-CD19 ANTIBODIES AND USES IN B CELL DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/957055 [patent_app_country] => US [patent_app_date] => 2013-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 90413 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13957055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9338353 [patent_doc_number] => 20140065135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'METHODS OF USING ANTI-PD-L1 ANTIBODIES AND THEIR USE TO ENHANCE T-CELL FUNCTION TO TREAT TUMOR IMMUNITY' [patent_app_type] => utility [patent_app_number] => 13/954796 [patent_app_country] => US [patent_app_date] => 2013-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 66052 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13954796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9199028 [patent_doc_number] => 20130338343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING KIDNEY DISEASE' [patent_app_type] => utility [patent_app_number] => 13/950553 [patent_app_country] => US [patent_app_date] => 2013-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11388 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13950553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9692054 [patent_doc_number] => 08822649 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Anti-CLTA4, anti-GLUT2 protein for the treatment of type 1 diabetes' [patent_app_type] => utility [patent_app_number] => 13/944036 [patent_app_country] => US [patent_app_date] => 2013-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 24981 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13944036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9222468 [patent_doc_number] => 20140017243 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'USE OF ADCC-OPTIMIZED ANTIBODIES FOR TREATING WEAK PATIENTS' [patent_app_type] => utility [patent_app_number] => 13/930070 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6888 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930070 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10533824 [patent_doc_number] => 09259440 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Methods for passive immunization' [patent_app_type] => utility [patent_app_number] => 13/930941 [patent_app_country] => US [patent_app_date] => 2013-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 27563 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11122025 [patent_doc_number] => 20160318999 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2016-11-03 [patent_title] => 'VISTA-Ig for Treatment of Autoimmune, Allergic and Inflammatory Disorders' [patent_app_type] => utility [patent_app_number] => 13/925094 [patent_app_country] => US [patent_app_date] => 2013-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 95550 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13925094 [rel_patent_id] =>[rel_patent_doc_number] =>)